MedTrace Logo

Rhythmic Entrainment in Bilingual Speakers With Dysarthria

NCT03645265 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2019-02-26

No results posted yet for this study

Summary

The objectives of this study are to determine i) the effect of rhythmic entrainment of speech with hand gestures and auditory rhythmic cues on intelligibility and speech naturalness in Spanish-accented speakers of English in two pathology groups: ataxic dysarthria and hypokinetic dysarthria secondary to idiopathic Parkinson's disease; and ii) the extent to which speech rate and effort are control parameters of entrainment. These objectives will be achieved with the following specific aims:

Specific Aim 1: Determine the effect of three rates of hand gestures and auditory rhythmic cues and the degree to which learning and carry-over occur.

Specific Aim 2: Determine the effect of increased speech effort, operationalized as clear speech, and the interaction effect of clear speech with hand gestures and auditory rhythmic cues.

Specific Aim 3: Investigate the perception of speech rhythm and its relationship to entrainment.

Conditions

  • Parkinson Disease
  • Ataxia

Interventions

BEHAVIORAL

Auditory

Use of auditory cues to improve speech production

BEHAVIORAL

Gestures

Use of gestures to improve speech production

Sponsors & Collaborators

  • University of Utah

    collaborator OTHER

  • Herbert H. Lehman College, City University of New York

    lead OTHER

Principal Investigators

  • Alison Behrman, PhD · Lehman College

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2019-02-20
Completion
2019-02-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03645265 on ClinicalTrials.gov